London
22 °C
Manchester
Glasgow
16 °C
Dublin
Belfast
Washington
28 °C
Denver
26 °C
Atlanta
Dallas
Houston Texas
29 °C
New Orleans
El Paso
Phoenix
Los Angeles
16 °C
29 °C
5 °C
10 °C
26 °C
CTT Pharma Reduces Authorized Share Count
NYSE - LSE
| RBGPF | 0.88% | 73.92 | $ | |
| RYCEF | 1.06% | 14.14 | $ | |
| CMSD | 0.5% | 23.83 | $ | |
| NGG | -0.01% | 71.425 | $ | |
| SCS | 2.75% | 16.555 | $ | |
| CMSC | 0.89% | 23.66 | $ | |
| GSK | 0.21% | 40.166 | $ | |
| BTI | -0.96% | 58.705 | $ | |
| RIO | 2.28% | 62.73 | $ | |
| AZN | 0.53% | 80.885 | $ | |
| RELX | 0.63% | 48.495 | $ | |
| JRI | 0.94% | 13.456 | $ | |
| BCC | 7.15% | 91.19 | $ | |
| BP | 1.79% | 34.67 | $ | |
| BCE | -0.82% | 25.51 | $ | |
| VOD | 0.78% | 11.953 | $ |
CTT Pharma Reduces Authorized Share Count
TAMPA, FL / ACCESS Newswire / February 3, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC:CTTH) is pleased to announce a reduction in its authorized share count by 150 million shares. CTT reduced the authorized share count from 300 million shares to 150 million shares. This change has already been filed with Delaware Division of Corporations. Furthermore, CTT's stock issuer has been notified and made the necessary corrections to reflect this change. This latest adjustment demonstrates CTT Pharma's ongoing commitment to optimizing its capital structure and delivering long-term value to shareholders. CTT is also in the process of gaining approval to uplist to the OTCQB and believes this decision benefits existing and future shareholders.
About CTT Pharmaceuticals Holdings, Inc.
CTT has patented technology in The United States, Europe, Canada and many additional countries to allow many actives on a dissolvable strip that include but are not limited to Nicotine, Vitamins, and Pharmaceuticals. CTT believes that there is a need for our technology in many industries, which includes a smoke-free nicotine strip that can be used as a smoking cessation product and deliver drugs that can help with pain management and anxiety. CTT Pharma incorporates micelle technology into its drug delivery. These strips would dissolve quickly, deliver low dose options and offer better bioavailability.
Investor Relations - 813-606-0060
SOURCE: CTT Pharmaceuticals Holdings, Inc.
View the original press release on ACCESS Newswire
L.Bautista--HdM
